Cementless Total Knee Arthroplasty Safe for Osteoporotic Patients Under 75, unravels study

Historical contraindications for TKA have included poor bone stock, a characteristic common to osteoporotic individuals. This study seeks to establish whether patients with osteoporosis who are below 75 years old and undergo cementless TKA have comparable implant-related and medical complications, hospital readmission rates, and 3-year implant survivability to those who undergo the cemented technique.

Using a national administrative claims database from 2010 to 2022, this study conducted a retrospective analysis of data. The inclusion criteria were patients 75 or younger with osteoporosis at diagnosis who received primary TKA. The cohort was split into two treatment groups according to the presence of cementless versus cemented TKA. To allow for a balanced comparison, propensity score matching was applied controlling for age, sex, obesity, and the Charleston Comorbidity Index (CCI), creating two well-matched groups: 1,321 patients in the cementless group and 6,602 in the cemented group. Primary endpoints consisted of the 90-day and 2-year implant-related complications, and the postoperative medical complications at 90 days and readmissions at 90 days. Additionally, Kaplan-Meier survival analysis was performed to assess the all-cause revision implant survivability rate at 3 years. The level of significance for type 1 error was set at P < 0.01 to minimize the error of the first type.

Key Findings

No statistically significant complications were detected between the cementless group and the cemented TKA regarding implant-related complications, medical complications, and admission rates within 90 days after the research.

The main results included the following.

• Implant-related complications: No significant difference between cemented and cementless groups.

• Medical complications within 90 days: Similar rates between both cohorts.

• 90-day readmissions: No statistically significant differences.

• Lengths of hospital stay were also comparable between the two groups.

The Kaplan-Meier analysis demonstrated that the 3-year implant survivability was nearly identical between the cemented and cementless TKA groups:

• Cemented TKA survivability: 97.6% (95% confidence interval [CI], 96.6 to 98.5),

• Cementless TKA survivability: 97.2% (95% CI, 96.7 to 97.7),

This study had strong evidence that when it comes to cementless TKA in osteoporotic patients under 75 years old, complications rates and implant survivability weren't significantly different compared with patients treated with cemented TKA. Surgeons might extend the indications of cementless TKA to a broader spectrum than standard and report the results in osteoporotic patients, accounting for variability in individual bone strength.

Reference: